PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12147302-0	2002	Reduction of bFGF-induced smooth muscle cell proliferation and endothelin receptor mRNA expression by mevastatin and atorvastatin.	Atorvastatin	117-129	fibroblast growth factor 2	Rattus norvegicus	13-17	
12147302-2	2002	The present study used aortic and cerebral vascular smooth muscle cells (SMC) from rat to investigate whether atorvastatin and mevastatin affect basic fibroblast growth factor (bFGF)-induced SMC proliferation and the mRNA expression of endothelin A (ET(A)) and endothelin B (ET(B)) receptors.	Atorvastatin	110-122	fibroblast growth factor 2	Rattus norvegicus	145-175	
12147302-2	2002	The present study used aortic and cerebral vascular smooth muscle cells (SMC) from rat to investigate whether atorvastatin and mevastatin affect basic fibroblast growth factor (bFGF)-induced SMC proliferation and the mRNA expression of endothelin A (ET(A)) and endothelin B (ET(B)) receptors.	Atorvastatin	110-122	fibroblast growth factor 2	Rattus norvegicus	177-181	
12147302-6	2002	In aortic SMC atorvastatin and mevastatin significantly inhibited bFGF-induced mRNA expression of endothelin ET(A) and ET(B) receptors (P<0.05).	Atorvastatin	14-26	fibroblast growth factor 2	Rattus norvegicus	66-70	
33236604-12	2020	Compared with the CON group, the survival rate of skin flaps, the number of microvessels in skin flaps and the levels of VEGF mRNA, bFGF mRNA, SOD, NO in skin flaps also increased with the dose of ATR, which reached a peak at 30 mg/kg ATR ( P<0.05).	Atorvastatin	197-200	fibroblast growth factor 2	Rattus norvegicus	132-136